Cellectis Archives -

Startup biotech already raised $300m earlier this year

Allogene raises another $120m to develop ‘off-the-shelf’ CAR-Ts

https://pharmaphorum.com/news/allogene-raises-another-120m-to-develop-off-the-shelf-car-ts/

Belldegrun and Chang’s Allogene to take over from Pfizer in R&D deal

Ex-Kite chiefs’ biotech to research ‘off-the-shelf’ CAR-Ts with Cellectis

https://pharmaphorum.com/news/ex-kite-chiefs-biotech-research-off-shelf-car-ts-cellectis/

US hospitals struggle to provide approved autologous therapies

Cellectis confident on ‘off the shelf’ CAR-Ts despite setbacks

https://pharmaphorum.com/news/pharma-looks-off-shelf-car-ts/

Regulator agrees to restart phase 1 trial of UCART 123

Cellectis gets FDA go-ahead to restart fatal CAR-T trial

https://pharmaphorum.com/news/cellectis-gets-fda-go-ahead-restart-fatal-car-t-trial/

Cellectis’ ‘off the shelf’ CAR-T cancer therapy has hit a major setback after the first patient treated in

Cellectis CAR-T trials on hold after patient death

https://pharmaphorum.com/news/cellectis-car-t-trials-hold-patient-death/

Companies hope to challenge traiblazers Novartis and Kite.

Servier and Pfizer begin trials for off-the-shelf T-cell cancer therapy

https://pharmaphorum.com/news/servier-and-pfizer-car-t/

Trials of Cellectis’ UCART123 have been given the go-ahead by the FDA, which will make it the first

Cellectis’ ‘off the shelf’ CAR-T ready for trials

https://pharmaphorum.com/news/cellectis-off-shelf-car-t-ready-trials/

Pfizer and Servier have snapped up the rights to UCART19, after the immunotherapy treatment showed hugely encouraging results

After taking lead in CAR-T, Cellectis drug snapped up by Pfizer and Servier

https://pharmaphorum.com/news/after-taking-lead-in-car-t-cellectis-drug-snapped-up-by-pfizer-and-servier/

Cellectis